USD 0.67 billion
Sepsis Diagnostics Market Size, Share, Growth Analysis, By Technology(Blood Culture Technology), By Application(Hospitals and Diagnostics Centres), By Product(Blood Culture Media, Assays and Reagent Kits, Instruments, Software), By Method(Conventional Diagnostics, Automated Diagnostics), By Pathogen Type(Bacterial Sepsis (Gram-Negative Bacterial Sepsis, Gram-Positive Bacterial Sepsis Fungal Sepsis), Other Pathogen Types), By Test Type(Laboratory Tests, Point-Of-Care Tests), By End Users(Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories, Academic Institute and Cros), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2237 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
59
|Figures:
75
Sepsis Diagnostics Market Insights
Sepsis Diagnostics Market size was valued at USD 1.07 billion in 2022 and is poised to grow from USD 0.63 billion in 2023 to USD 1.30 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2024-2031).
Sepsis diagnostics is a vital section of the healthcare industry committed to the detection and management of sepsis. The global market is driven by the growing number of hospitalizations because of the infections, mainly in vulnerable populations like immunocompromised groups of individuals and elderly population. Furthermore, technological improvements and growing regulatory initiatives are propelling the growth of the sepsis diagnostics market. Modernizations in diagnostics technologies like multiplex assays and rapid PCR tests are enhancing the accuracy and speed of detection of sepsis. Moreover, most healthcare organizations and governments are encouraging and developing and supporting guidelines for optimal management of sepsis, driving the growth of the market.
Nevertheless, the market is considerably hampered by significant costs associated with improved diagnostic tests that may impede accessibility, especially in the limited-resource facilities. In addition, the complexity associated with diagnosis and growing need for standardization may also limit the market growth. Sepsis may be difficult to diagnose owing to its non-specific symptoms, thus resulting in delayed treatments or possible misdiagnosis. Also, fluctuations in testing protocols and understanding may hamper its broad adoption of novel technologies. Yet, the market is opportune to factors like the growing development of biomarkers, advancements like rapid testing solutions and integration of ML and AI, and collaborative R&D.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Blood Culture Technology
Fastest Growth
Immunoassays
Growth Rate
9.8% CAGR
Global Sepsis Diagnostics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Sepsis Diagnostics Market Segmental Analysis
Sepsis Diagnostics market is segmented by Technology, Product, Method, Pathogen Type, Test Type, End Users, Region. Based on Technology, the market can be segmented into Blood Culture Technology, Immunoassays, Molecular Diagnostics (Polymerase Chain Reaction, Microarrays, Peptides Nucleic Acid- Fluorescent In Situ Hybridization, DNA Sequencing, Syndromic Panel Based Testing), Flow Cytometry, Microfluidics, Biomakers. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments, Software. Based on Method the market is segmented into Conventional Diagnostics, Automated Diagnostics. Based on Pathogen Type the market is segmented into Bacterial Sepsis (Gram-Negative Bacterial Sepsis, Gram-Positive Bacterial Sepsis Fungal Sepsis), Other Pathogen Types. Based on End Users the market is segmented into Hospitals and Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories, Academic Institute and Cros. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Product
Based on product, the sepsis diagnostics market is categorized into blood culture media, assays and reagent kits, instruments, and software. The blood culture media segment held a notable share of the market in the previous years and is expected to lead over the forecast period, owing to specificity, high sensitivity, and well-established protocols. Blood cultures are regarded as the gold standard for detecting pathogens in blood flow, thus increasing its accuracy and significance for sepsis diagnosis. They hold higher sensitivity in identifying a broader range of fungi and bacteria needed for appropriate and timely treatment. Also, there are established techniques and protocols for blood culture testing in clinics, resulting in its reliable use.
On the other hand, the assays and reagent kits segment are projected to grow considerably over the forecast period owing to speedy testing capabilities, diverse applications, and mounting demand for POC testing. Reagents kits and assays allow efficient and quick testing for treatment and timely diagnosis of sepsis. They can capably identify a broader range of biomarkers and pathogens, enabling personalized treatment options and targeted diagnostics. Also, the rising shift towards POC or point-of-care testing improves the adoption of reagent kits and assays since they are mostly designed to be utilized in diverse clinical settings. These factors are aiding the growth of the segment, thus impacting market growth.
Analysis by End Users
Based on end users, the market is segmented into hospitals and specialty clinics, pathology and reference laboratories, research laboratories, and academic institute and CROs. The hospitals and specialty clinics segment held a notable market share in the previous years and is expected to continue dominance over the forecast period as well owing to high patient volume, better critical care infrastructure, and emergency services. Specialty clinics and hospitals manage a large patient population, mainly for individuals at a higher risk of sepsis that need diagnostic testing. These settings are well-equipped with a trained workforce and improved diagnostic technologies to handle sepsis. Speedy diagnosis in emergency departments is vital for sepsis management, resulting in increased demand of diagnostics in these settings.
On the other hand, the pathology and reference laboratories segment will hold a remarkable market share in the coming years owing to improved testing capabilities, high volume testing, and specialization. These labs are well-equipped with skilled laborers and high-tech diagnostic technologies, allowing conduct of complex tests, comprising molecular diagnostics and blood culture. They handle huge number of samples, offering vital testing services, demanding sepsis diagnosis. They hold expertise in infectious disease testing, increasing their significance in detection and confirmation for sepsis-associated pathogens. Also, these laboratories comply with stringent quality control standards, confirming accurate and reliable results that are important for effective management of sepsis.
Global Sepsis Diagnostics Market Size By Product
To get detailed analysis on other segments, Request For Free Sample Report
Sepsis Diagnostics Market Regional Insights
Geographically, North America dominated the market in the previous years and is expected to lead over the forecast period owing to the advanced healthcare infrastructure, increased cases of sepsis, and robust research and development investment. North America has a developed healthcare system with superior technology and a broad range of resources for diagnosis and associated services. Moreover, growing cases of sepsis and associated health conditions are notably impacting the demand for reliable and accurate diagnostic solutions. Also, the region is home to the leading pharmaceutical and biotech companies that are heavily investing in R&D, resulting in modernized diagnostic technologies. The key players profiled in the region include Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Hologic Inc., Luminex Corporation, Meridian Bioscience, Inc., and more.
Asia-Pacific is projected to emerge as the fastest-growing region due to the speedy expansion of healthcare, growing cases of infections, and growing awareness of sepsis. Most nations in the region are enhancing their healthcare infrastructure, which increases the accessibility to improved diagnostic services and technologies. Also, rising cases of sepsis and infectious diseases are resulting in increased demand for reliable and accurate diagnostic solutions. Furthermore, the awareness of sepsis and its severity is rising among the public and healthcare professionals, thus impacting early diagnosis and treatment. Private sectors and governments are heavily investing in research and development in diagnostic technologies and tools, impacting regional growth.
Global Sepsis Diagnostics Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Sepsis Diagnostics Market Dynamics
Drivers
Growing Awareness Initiatives and Education
- Increasing awareness and training programs for medical professionals regarding the significance of early detection of sepsis and its management is increasing. This is notably contributing to the steady adoption of diagnostic tests and associated services. Moreover, growing number of initiatives for educating the public for the symptoms and signs of sepsis promote timely medical guidance, thus resulting in diagnosis and testing.
Growing Demand for POC Testing
- The inclination towards POC testing enables quick diagnosis in critical and emergency settings. This increases the use of easy-to-use and portable diagnostic devices. Also, the rising trend towards decentralized medical services is rising the demand for speedy and accurate diagnostic tests and services that can be effectively conducted outside the conventional laboratory settings.
Restraints
Complexity Associated with Diagnosis
- Sepsis presents a broader range of non-specific signs and symptoms, which increases complexity of early diagnosis. This intricacy results in delayed treatment or misdiagnosis, thus decreasing the perceived impact of diagnostics. Precise diagnosis of sepsis needs mixture of tests, which may complicate the process of diagnosis and delay result time, negatively affecting the market growth.
Fluctuations in Testing Procedures
- Disparities in testing protocols and understanding results may lead to fluctuations in sepsis diagnosis. This could potentially lose trust in diagnostic tools. Variations in clinical guidelines about the utilization of diagnostic tests and services may result in ample confusion among healthcare providers and affect the adoption of novel technologies. Hence, inconsistent clinical guidelines may negatively impact market growth.
Request Free Customization of this report to help us to meet your business objectives.
Sepsis Diagnostics Market Competitive Landscape
The competitive landscape of the global sepsis diagnostics market is a highly competitive market impacted by the leading trends and the mix of prominent players and progressing vendors. The top-ranking companies, Abbott Laboratories, Roche, BioMérieux, Becton Dickinson, and Siemens Healthineers that are dominating the market with their broad distribution network and innovative offerings. Startups and the new entrants are modernizing new technologies like rapid testing solutions and AI-based diagnostics that improve competition and help the emerging enterprises to progress further. Improvements and expanding geographic presence are also supported by growing number of alliances between diagnostic companies, research institutes, and healthcare providers.
Top Player’s Company Profiles in Global Sepsis Diagnostics Market
- Abbott Laboratories (US)
- bioMérieux SA (France)
- Cepheid (US)
- F. Hoffmann-La Roche AG (Switzerland)
- Hologic Inc. (US)
- Imbio LLC (US)
- Luminex Corporation (US)
- MedMira Inc. (Canada)
- Meridian Bioscience, Inc. (US)
- Nanosphere (US)
- QIAGEN N.V. (Netherlands)
- Thermo Fisher Scientific Inc. (US)
- T2 Biosystems, Inc. (US)
- Biomarck Pharmaceuticals Ltd. (UK)
- Magnitude Biosciences (US)
- Axis-Shield Diagnostics Ltd. (UK)
- Biocartis Group NV (Belgium)
- Inflammatix Inc. (US)
- OpGen, Inc. (US)
Global Sepsis Diagnostics Market Recent Developments
- In April 2024, Abbott announced that its i-STAT TBI cartridge received U.S. FDA clearance to be utilized with whole blood. This enables doctors to evaluate patients with possible concussion at bedside and gain lab-quality in nearly 15 minutes. Earlier, these test samples had to be sent to the laboratories for testing and processing.
- In March 2024, Becton, Dickinson and Company declared partnership with The Great Orchestra of Christmas Charity (GOCC) to increase access to the improved testing for sepsis management and (BSIs) Bloodstream Infections at more than 150 clinics and hospitals in Poland.
- In September 2024, Cepheid announced a key partnership with Fleming Initiative to fight antimicrobial resistance. The Fleming Initiative combines research scientists, clinicians, policymakers, public and commercial partners, and behavioral experts to offer expertise, networks, and skills to offer equitable approaches to AMR on the global scale. The collaboration will focus on key areas of AMR, including techniques for sepsis to detect and cure patients with specific sepsis response state.
Sepsis Diagnostics Key Market Trends
- Improvements in Molecular Diagnostics: In recent years, the use of next-generation sequencing (NGS) and polymerase chain reaction (PCR) has increased significantly with huge prominence. These techniques enable accurate and speedy detection of pathogens that help in majorly reducing the time needed for diagnosis in comparison with former culture methods. This is vital for early mediation in sepsis management.
- Incorporation of Biomarkers: The use of biomarkers has become important in early detection. Currently, there is a growing emphasis on detecting certain biomarkers related to sepsis like (CRP) C-reactive protein, (PCT) procalcitonin, and (IL-6) interleukin-6. These biomarkers aid in differentiating sepsis from several inflammatory conditions and aid in treatment decisions. This results in better patient outcomes by streamlining quick diagnosis and more targeted therapies.
Sepsis Diagnostics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the sepsis diagnostics market is considerably progressing due to the growing emphasis on personalized medicine for better treatment of sepsis, increasing collaborations and partnerships, and increasing prevalence of sepsis. The market is also propelled by growing technological improvements in diagnostic tools like multiplex assays, molecular diagnostics, and rapid PCR tests and progressing markets in Asia-Pacific. However, the market is hampered by challenges like lengthy approval procedures, compliance issues, and diagnosis complexity. The market is also restrained by the rising need for well-trained professionals. North America is anticipated to dominate the market owing to the greater awareness among healthcare staff and the public, favorable regulatory framework for enhancing sepsis care management, and strong R&D infrastructure. Nonetheless, a few opportunities for the growth of the sepsis diagnostics market include the growth of remote monitoring and telemedicine and growing awareness programs.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.07 billion |
| Market size value in 2031 | USD 1.30 billion |
| Growth Rate | 8.0% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Sepsis Diagnostics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Sepsis Diagnostics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Sepsis Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Sepsis Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Sepsis Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Sepsis Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
